Alex Den­ner tar­gets Amarin, de­mand­ing board chair re­sign in call for share­hold­er meet­ing

VC man­ag­ing part­ner and Carl Ic­ahn pro­tégé Alex Den­ner has built him­self a track record as an ac­tivist in­vestor. And he now has an­oth­er biotech in his sights.

Saris­sa Cap­i­tal, the bio­phar­ma VC that Den­ner found­ed in 2013 and cur­rent­ly man­ages, re­leased a state­ment Tues­day ac­cus­ing Irish drug­mak­er Amarin of mak­ing its board re­fresh­ment process a “cha­rade” led by Amarin’s chair­man ap­point­ed last year, Per Wold-Olsen.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER